Latest filing published 13 Apr 2009 for HARVARD BIOSCIENCE INC.
Insider track record
No signal scores available.
Closed purchases
Based on 71 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -41.3%Entry US$34.72 · Close at T+365 US$20.39
- -47.5%Entry US$28.89 · Close at T+365 US$15.16
- -48.9%Entry US$28.81 · Close at T+365 US$14.71
- -30.4%Entry US$37.38 · Close at T+365 US$26.00
- -8.0%Entry US$33.36 · Close at T+365 US$30.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Skystone Advisors LLC: trading record in brief
Skystone Advisors LLC is a declared insider at 2 companies; the most frequent names are Harvard Bioscience Inc and Collegiate Pacific Inc. We count 113 filings; the first trade dates from 31 May 2006 and the latest from 1 April 2009.
Both buying and selling appear: 92 purchases worth €6.9M, against 20 sales worth €6.1M. Netting one side against the other leaves €846k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2009: no purchases and 3 sales on the market.
In size, the median ticket on the buying side is €24k. Looking at 71 purchases old enough to measure, the stock rose over the following 90 days in 80% of cases; the median change was +5.9%. This is a record of the past, not a forecast.
The newest entry dates from 13 April 2009: a transaction, in Harvard Bioscience Inc. The latest purchase dates back some time: it was published 6,884 days ago, on 3 January 2008. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Skystone Advisors LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,746,988 shares0Common StockSEC:0000929638-09-000660:0
- 1,300 shares@ US$3.10Common StockSEC:0000929638-09-000539:0
- 5,860 shares@ US$3.00Common StockSEC:0000929638-09-000539:1
- 7,958 shares@ US$2.75Common StockSEC:0000929638-09-000486:0
- 1,000,000 shares@ US$5.00Common StockSEC:0000929638-08-000321:0
- 88,300 shares@ US$12.0154Common StockSEC:0000929638-08-000107:0
- 22,200 shares@ US$11.8607Common StockSEC:0000929638-08-000107:1
- 41,000 shares@ US$11.4003Common StockSEC:0000929638-08-000076:0
- 400 shares@ US$11.39Common StockSEC:0000929638-08-000076:1
- 4,300 shares@ US$11.3637Common StockSEC:0000929638-08-000076:2
- 100,000 shares@ US$11.3815Common StockSEC:0000929638-08-000076:3
- 5,000 shares@ US$11.7508Common StockSEC:0000929638-08-000076:4
- 14,800 shares@ US$11.7794Common StockSEC:0000929638-08-000076:5
- 5,700 shares@ US$11.8077Common StockSEC:0000929638-08-000076:6
- 10,000 shares@ US$11.25Common StockSEC:0000929638-08-000066:0
- 27,284 shares@ US$11.3382Common StockSEC:0000929638-08-000049:0
- 4,912 shares@ US$11.3353Common StockSEC:0000929638-08-000049:1
- 19,600 shares@ US$11.2826Common StockSEC:0000929638-08-000049:2
- 16,100 shares@ US$11.1595Common StockSEC:0000929638-08-000049:3
- 700 shares@ US$11.25Common StockSEC:0000929638-08-000049:4
- 4,362 shares@ US$4.5079Common StockSEC:0000929638-08-000004:0Canonical exit: 30 Mar 2008 (T+90)
- 9,177 shares@ US$3.8734Common StockSEC:0000929638-07-000691:0Canonical exit: 18 Feb 2008 (T+90)
- 10,550 shares@ US$3.8171Common StockSEC:0000929638-07-000680:0Canonical exit: 13 Feb 2008 (T+90)
- 16,385 shares@ US$3.7985Common StockSEC:0000929638-07-000680:1Canonical exit: 13 Feb 2008 (T+90)
- 8,158 shares@ US$3.8999Common StockSEC:0000929638-07-000680:2Canonical exit: 14 Feb 2008 (T+90)
25 of 109 declarations
